Drug transport across pulmonary epithelial cell monolayers: effects of particle size, apical liquid volume, and deposition technique

M Bur, H Huwer, L Muys, CM Lehr - Journal of aerosol medicine and …, 2010 - liebertpub.com
Background: Pulmonary cell cultures are increasingly used to predict in vivo drug absorption
after inhalation, similar to intestinal cell culture models that have already been well …

Toxicity of orally inhaled drug formulations at the alveolar barrier: parameters for initial biological screening

E Fröhlich - Drug Delivery, 2017 - Taylor & Francis
Oral delivery is the most common mode of systemic drug application. Inhalation is mainly
used for local therapy of lung diseases but may also be a promising route for systemic …

In vivo animal models for drug delivery across the lung mucosal barrier

SA Cryan, N Sivadas, L Garcia-Contreras - Advanced drug delivery reviews, 2007 - Elsevier
Over recent years the research focus within the field of respiratory drug delivery has
broadened to include a wide range of potential applications for inhalation by delivering …

In vitro, in vivo and ex vivo models for studying particle deposition and drug absorption of inhaled pharmaceuticals

K Nahar, N Gupta, R Gauvin, S Absar, B Patel… - European journal of …, 2013 - Elsevier
Delivery of therapeutic agents via the pulmonary route has gained significant attention over
the past few decades because this route of administration offers multiple advantages over …

A new Pharmaceutical Aerosol Deposition Device on Cell Cultures (PADDOCC) to evaluate pulmonary drug absorption for metered dose dry powder formulations

S Hein, M Bur, UF Schaefer, CM Lehr - European Journal of Pharmaceutics …, 2011 - Elsevier
Absorption studies with aerosol formulation delivered by metered dose inhalers across cell-
and tissue-based in vitro models of the pulmonary epithelia are not trivial due to the …

Models to evaluate the barrier properties of mucus during drug diffusion

L Liu, C Tian, B Dong, M Xia, Y Cai, R Hu… - International Journal of …, 2021 - Elsevier
Mucus is widely disseminated in the nasal cavity, oral cavity, respiratory tract, eyes,
gastrointestinal tract, and reproductive tract to prevent the invasion of pathogenic bacteria …

Influence of particle size and material properties on mucociliary clearance from the airways

A Henning, M Schneider, N Nafee, L Muijs… - Journal of aerosol …, 2010 - liebertpub.com
Mucociliary clearance (MC), designed by evolution to eliminate inhaled and possibly
noxious material from the airways, considerably limits the benefit of inhalation therapy …

Disruption of the mucus barrier by topically applied exogenous particles

SL McGill, HDC Smyth - Molecular pharmaceutics, 2010 - ACS Publications
The mucus barrier is well established as a formidable barrier to exogenous substances and
forms the first line of defense for mucosal surfaces. Drugs and particle systems are known to …

Airway liquid: a barrier to drug diffusion?

JG Widdicombe - European Respiratory Journal, 1997 - Eur Respiratory Soc
The paper by HOHLFELD et al.[1] in this issue shows that, in rats, bronchoconstriction due to
inhaled acetylcholine is inhibited by inhaled aerosols of surfactant. Bronchoconstriction was …

Integrated in vitro experimental modelling of inhaled drug delivery: deposition, dissolution and absorption

RC Sadler, D Prime, PK Burnell, GP Martin… - Journal of drug delivery …, 2011 - Elsevier
This article reviews the state-of-the-art for in vitro experimental modelling involving the
deposition of respirable particles onto respiratory epithelial cells for the purpose of studying …